Friday October 20, 2017 02:50

Heathcare Press Release : 03 Oct 2017

Merck Invests EUR 35 Million in its Italian Biotech Manufacturing Site of Heathcare—03 Oct 17

- Isolator technology represents best practice for the aseptic filling of injectable medicines and ensures the highest quality standards - Investment supports growth of Merck's portfolio of biotech medicines Merck, a leading science and technology